Method development for the production of clinically relevant doses of human pluripotent stem cell derived cardiomyocytes

Authors

Andrew Prowse, The University of Queensland, AustraliaFollow
Steve Dingwall, The University of Queensland
Zoe Clayton, The Westmead Institute for Medical Research
Dinesh Selvakumar, The Westmead Institute for Medical Research
James Chong, The Westmead Institute for Medical Research
Peter Gray, The University of Queensland

Conference Dates

February 4 - 8, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

Andrew Prowse, Steve Dingwall, Zoe Clayton, Dinesh Selvakumar, James Chong, and Peter Gray, "Method development for the production of clinically relevant doses of human pluripotent stem cell derived cardiomyocytes" in "Advancing Manufacture of Cell and Gene Therapies VIII", Fernanda Masri, Cytomos, United Kingdom; Carolyn Yeago, CY Solutions LLC, USA; Gargi Maheshwari, BMS, USA; John Moscariello, BMS, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/cell_gene_therapies_viii/59